| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| GMREGlobal Medical REIT Inc. | 483.6M | 36.07 | 116.35 | -1.79% | 1.69% | 0.49% | 1.18 | |
| SILASila Realty Trust, Inc. | 1.33B | 24.11 | 32.15 | -1.17% | 20.28% | 2.91% | 9.77% | 0.40 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.06M | 8.08M | 30.22M | 53.19M | 70.73M | 93.52M | 115.8M | 137.17M | 140.93M | 138.41M |
| Revenue Growth % | 4.42% | 2.92% | 2.74% | 0.76% | 0.33% | 0.32% | 0.24% | 0.18% | 0.03% | -0.02% |
| Property Operating Expenses | 1.02M | 1.43M | 1.86M | 3.72M | 6.54M | 10.87M | 15.49M | 25.19M | 28.08M | 29.25M |
| Net Operating Income (NOI) | - | - | - | - | - | - | - | - | - | - |
| NOI Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 1.52M | 8.1M | 18.61M | 27.23M | 14.25M | 82.65M | 63.33M | 73.27M | 74.99M | 76.48M |
| G&A Expenses | 865.14K | 5.73M | 8.61M | 9.96M | 14.25M | 29.96M | 16.45M | 16.55M | 16.85M | 21.12M |
| EBITDA | -865.14K | 8.21M | 30.34M | 53.58M | 73.7M | 53M | 84.3M | 96.37M | 96.87M | 88.76M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 659.67K | 10.43M | 23M | 31.33M | 23.76M | 36.82M | 47.31M | 57.66M | 59.01M | 56.08M |
| D&A / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | -1.52M | -2.21M | 7.35M | 22.24M | 49.94M | 0 | 36.99M | 38.71M | 37.86M | 32.68M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 1.52M | 4.14M | 7.43M | 14.97M | 17.47M | 18.68M | 19.7M | 25.23M | 30.89M | 28.69M |
| Interest Coverage | -1.00x | -0.54x | 0.99x | 1.49x | 2.86x | - | 1.88x | 1.53x | 1.23x | 1.14x |
| Non-Operating Income | 614K | 2.19M | 2.52M | -7.29M | 22.88M | -16.18M | -1.05M | -6.51M | -14.76M | -2.7M |
| Pretax Income | -1.61M | -6.35M | -87K | 14.56M | 9.59M | -2.5M | 18.34M | 20M | 21.73M | 6.69M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 1.52M | 4.27M | -49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | -1.61M | -6.35M | -38K | 13.49M | 9.23M | -1.93M | 17.62M | 19.14M | 20.61M | 6.63M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -1.47% | -2.95% | 0.99% | 356% | -0.32% | -1.21% | 10.15% | 0.09% | 0.08% | -0.68% |
| Funds From Operations (FFO) | - | - | - | - | - | - | - | - | - | - |
| FFO Margin % | - | - | - | - | - | - | - | - | - | - |
| FFO Growth % | -0.82% | 5.29% | 4.64% | 0.95% | -0.26% | 0.06% | 0.86% | 0.18% | 0.04% | -0.21% |
| FFO per Share | - | - | - | - | - | - | - | - | - | - |
| FFO Payout Ratio % | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -161.00 | -17.00 | -0.05 | 15.25 | -6.00 | -11.25 | -0.86 | -2.00 | 5.75 | 0.31 |
| EPS Growth % | 0.52% | 0.89% | 1% | 322.05% | -1.39% | -0.88% | 0.92% | -1.34% | 3.88% | -0.95% |
| EPS (Basic) | -161.00 | -17.00 | -0.05 | 15.25 | -6.00 | -11.25 | -0.86 | -2.00 | 5.75 | 0.31 |
| Diluted Shares Outstanding | 10K | 372.08K | 784.68K | 878.84K | 1.35M | 1.85M | 2.43M | 2.62M | 2.62M | 2.64M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 65.33M | 227.32M | 474.57M | 636.1M | 884.93M | 1.1B | 1.26B | 1.39B | 1.27B | 1.26B |
| Asset Growth % | 1.64% | 2.48% | 1.09% | 0.34% | 0.39% | 0.24% | 0.15% | 0.1% | -0.09% | -0.01% |
| Real Estate & Other Assets | 93.65K | 1.77M | 7.2M | 589.99M | 18.19M | 21.98M | 1.14B | 1.26B | 1.17B | 1.17B |
| PP&E (Net) | 55.15M | 196.37M | 426.26M | 139K | 792.98M | 978.71M | 3.81M | 5.03M | 10.97M | 7.27M |
| Investment Securities | 0 | -1000K | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 1000K |
| Total Current Assets | 10.09M | 22.04M | 9.46M | 9.68M | 32.3M | 42.05M | 24.95M | 30.53M | 14.35M | 17.35M |
| Cash & Equivalents | 9.18M | 19.67M | 5.11M | 3.63M | 2.77M | 5.51M | 7.21M | 4.02M | 1.28M | 6.82M |
| Receivables | 23.3K | 212.44K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 901.94K | 0 | 3.64M | 2.96M | 10.37M | 10.75M | 11.5M | 18.27M | 6.12M | 2.84M |
| Intangible Assets | 0 | 7.14M | 31.65M | 36.29M | 41.46M | 52.27M | 87.94M | 91.31M | 65.97M | 54.07M |
| Total Liabilities | 65.47M | 72.29M | 215.56M | 336.35M | 424.58M | 643.15M | 625.91M | 744.2M | 661.89M | 700.57M |
| Total Debt | 63.94M | 66.53M | 203.44M | 315.01M | 395.06M | 607.62M | 579.86M | 704.65M | 624.19M | 653.59M |
| Net Debt | 54.75M | 46.86M | 198.34M | 311.38M | 392.3M | 602.11M | 572.64M | 700.64M | 622.91M | 646.78M |
| Long-Term Debt | 23.49M | 66.11M | 200.69M | 315.01M | 386.17M | 586.58M | 57.16M | 57.67M | 25.9M | 14.4M |
| Short-Term Borrowings | 0 | 1000K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Capital Lease Obligations | 0 | 277.92K | 1.29M | 2.03M | 2.4M | 2.96M | 8.13M | 10.54M | 12.96M | 7.46M |
| Total Current Liabilities | 1.53M | 32.46M | 173.59M | 288.03M | 24.84M | 37.84M | 540.58M | 670.53M | 619.34M | 671.45M |
| Accounts Payable | 683.86K | 574K | 2.02M | 3.66M | 5.07M | 7.28M | 10.34M | 13.82M | 12.78M | 16.47M |
| Deferred Revenue | 0 | 3.19M | 0 | 0 | 0 | 0 | 0 | 4.44M | 5.09M | 6.73M |
| Other Liabilities | 847.17K | -26.56M | 3.16M | 5.18M | 11.16M | 15.78M | 20.04M | 5.46M | 3.69M | 7.26M |
| Total Equity | -138.61K | 200.02M | 259.01M | 299.75M | 460.35M | 457.76M | 637.58M | 649.07M | 605.81M | 555.92M |
| Equity Growth % | -1.07% | 1444.03% | 0.29% | 0.16% | 0.54% | -0.01% | 0.39% | 0.02% | -0.07% | -0.08% |
| Shareholders Equity | -138.61K | 155.03M | 246.34M | 269.3M | 430.27M | 444.81M | 622.78M | 632.98M | 583.58M | 534.13M |
| Minority Interest | 0 | 44.99M | 12.68M | 30.45M | 30.08M | 12.96M | 14.79M | 16.08M | 22.23M | 21.79M |
| Common Stock | 250 | 17.61K | 22K | 26K | 44K | 49K | 65K | 66K | 66K | 67K |
| Additional Paid-in Capital | 3.01M | 172M | 205.79M | 243.04M | 433.33M | 504.79M | 711.41M | 721.99M | 722.42M | 734.22M |
| Retained Earnings | -3.15M | -16.99M | -34.43M | -45.01M | -71.39M | -116.77M | -157.02M | -198.71M | -238.98M | -293.74M |
| Preferred Stock | 0 | 0 | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M |
| Return on Assets (ROA) | -0.04% | -0.04% | -0% | 0.02% | 0.01% | -0% | 0.01% | 0.01% | 0.02% | 0.01% |
| Return on Equity (ROE) | -1.85% | -0.06% | -0% | 0.05% | 0.02% | -0% | 0.03% | 0.03% | 0.03% | 0.01% |
| Debt / Assets | 0.98% | 0.29% | 0.43% | 0.5% | 0.45% | 0.55% | 0.46% | 0.51% | 0.49% | 0.52% |
| Debt / Equity | - | 0.33x | 0.79x | 1.05x | 0.86x | 1.33x | 0.91x | 1.09x | 1.03x | 1.18x |
| Net Debt / EBITDA | - | 5.71x | 6.54x | 5.81x | 5.32x | 11.36x | 6.79x | 7.27x | 6.43x | 7.29x |
| Book Value per Share | -13.86 | 537.56 | 330.09 | 341.07 | 339.84 | 247.41 | 262.85 | 247.88 | 231.05 | 210.78 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -208.8K | -2.72M | 11.6M | 24.83M | 36.43M | 34.52M | 68.97M | 76.54M | 68.44M | 70.05M |
| Operating CF Growth % | -0.43% | -12.04% | 5.26% | 1.14% | 0.47% | -0.05% | 1% | 0.11% | -0.11% | 0.02% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | -1.61M | -6.35M | -87K | 14.56M | 9.59M | -2.5M | 18.34M | 20M | 20.61M | 6.63M |
| Depreciation & Amortization | 659.67K | 2.38M | 10.13M | 17.96M | 25.52M | 36.82M | 47.31M | 57.66M | 59.01M | 56.08M |
| Stock-Based Compensation | 0 | 1.68M | 1.8M | 2.67M | 3.34M | 5.32M | 5.81M | 4.68M | 4.24M | 5.1M |
| Other Non-Cash Items | 126.53K | 350.44K | 1.48M | 1.75M | 1.76M | 1.56M | 1.33M | -4.06M | -9.73M | 1.01M |
| Working Capital Changes | 614.24K | -780.96K | -1.71M | -4.43M | -3.77M | -7.65M | -3.82M | -1.74M | -5.69M | 1.21M |
| Cash from Investing | -32.34M | -150.36M | -252.65M | -151.62M | -258.2M | -223.67M | -194.66M | -137.25M | 67.62M | -45.94M |
| Acquisitions (Net) | 0 | -140.37K | 0 | 0 | 0 | -5.09M | 0 | 0 | 0 | 0 |
| Purchase of Investments | -385.1K | -797.82K | -426K | -373K | 0 | -1.54M | 0 | 0 | 0 | 0 |
| Sale of Investments | 0 | 242.04K | 21K | 1000K | 0 | 208K | 0 | 0 | 0 | 1000K |
| Other Investing | -32.34M | 242.04K | -433K | 5.26M | -3.21M | 1.54M | -2.41M | 13.68M | 67.62M | -103.56M |
| Cash from Financing | 41.64M | 163.57M | 226.49M | 124.51M | 224.11M | 192.72M | 127.7M | 62.41M | -143.79M | -21.89M |
| Dividends Paid | -255.6K | -3.88M | -15.98M | -24.79M | -34.99M | -45.77M | -58.32M | -64.24M | -64.85M | -65.69M |
| Common Dividends | -256K | -3.88M | -15.23M | -18.96M | -29.17M | -39.94M | -52.5M | -58.42M | -59.02M | -59.87M |
| Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K |
| Share Repurchases | 0 | 0 | 0 | -263K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -389.14K | -2.9M | -3.06M | -3.1M | -1.33M | -2.83M | -8.89M | -5.19M | 7.15M | 252K |
| Net Change in Cash | 9.1M | 10.49M | -14.56M | -2.27M | 2.34M | 3.57M | 2.01M | 1.7M | -7.73M | 2.22M |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 88.81K | 9.18M | 19.67M | 7.11M | 4.84M | 7.18M | 10.75M | 12.76M | 14.46M | 6.72M |
| Cash at End | 9.18M | 19.67M | 5.11M | 4.84M | 7.18M | 10.75M | 12.76M | 14.46M | 6.72M | 8.94M |
| Free Cash Flow | -32.41M | -153.18M | -240.62M | -156M | -220.38M | -184.27M | -132.69M | -79.66M | 58.39M | -25.07M |
| FCF Growth % | -0.47% | -3.73% | -0.57% | 0.35% | -0.41% | 0.16% | 0.28% | 0.4% | 1.73% | -1.43% |
| FCF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | -94.96 | 10.94 | 29.26 | 51 | 24.36 | 18.86 | 26.77 | 29.33 | 30.37 | 23.78 |
| FFO Payout Ratio | -26.96% | 95.24% | 66.34% | 42.31% | 88.41% | 114.48% | 80.86% | 76.06% | 74.13% | 95.46% |
| NOI Margin | 50.54% | 82.25% | 93.85% | 93.01% | 90.76% | 88.38% | 86.63% | 81.64% | 80.07% | 78.87% |
| Net Debt / EBITDA | - | 5.71x | 6.54x | 5.81x | 5.32x | 11.36x | 6.79x | 7.27x | 6.43x | 7.29x |
| Debt / Assets | 97.87% | 29.27% | 42.87% | 49.52% | 44.64% | 55.19% | 45.89% | 50.58% | 49.24% | 52.02% |
| Interest Coverage | -1.00x | -0.54x | 0.99x | 1.49x | 2.86x | - | 1.88x | 1.53x | 1.23x | 1.14x |
| Book Value / Share | -13.86 | 537.56 | 330.09 | 341.07 | 339.84 | 247.41 | 262.85 | 247.88 | 231.05 | 210.78 |
| Revenue Growth | 441.97% | 291.89% | 274.07% | 76% | 32.96% | 32.23% | 23.83% | 18.45% | 2.75% | -1.79% |
Global Medical REIT Inc. (GMRE) has a price-to-earnings (P/E) ratio of 116.4x. This suggests investors expect higher future growth.
Global Medical REIT Inc. (GMRE) reported $148.0M in revenue for fiscal year 2024.
Global Medical REIT Inc. (GMRE) saw revenue decline by 1.8% over the past year.
Yes, Global Medical REIT Inc. (GMRE) is profitable, generating $2.5M in net income for fiscal year 2024 (4.8% net margin).
Yes, Global Medical REIT Inc. (GMRE) pays a dividend with a yield of 62.93%. This makes it attractive for income-focused investors.
Global Medical REIT Inc. (GMRE) has a return on equity (ROE) of 1.1%. This is below average, suggesting room for improvement.
Global Medical REIT Inc. (GMRE) generated Funds From Operations (FFO) of $60.7M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Global Medical REIT Inc. (GMRE) offers a 62.93% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.